Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05598645

Thulium Fiber Laser (TFL) Versus Holmium MOSES Laser for Ureteroscopic Management of Kidney Stones

Thulium Fiber Laser (TFL) Versus Holmium MOSES Laser in Ureteroscopic Management of Kidney Stones 10-20mm: A Randomized Prospective Clinical Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
174 (estimated)
Sponsor
Thunder Bay Regional Health Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to compare the efficacy and safety of both types of lasers, Holmium MOSES and TFL, in management of kidney stones requiring treatment.

Detailed description

The prevalence of kidney stones has been increasing over the last two decades with lifetime recurrence risk reported to be as high as 50%. Holmium lasers are nowadays considered the "gold standard" for treatment of urinary tract stones. Recently, the holmium laser urology platform from Lumenis has been updated to include a new technology called MOSES, which provides improved energy delivery of the laser to treat the stones, reduces migration of the stone during the procedure, and limits potential collateral tissue damage. A new generation of lasers has evolved due to the advances in laser fiber technology, leading to the development of the Thulium Fiber Laser (TFL). TFL can operate within a large range of energy, frequency and pulse duration settings. The small fiber size is one of the main advantages of TFL, as it allows better endoscope performance through easier deflection and bigger working channel space. Furthermore, it produces small stone fragments and better dusting capabilities compared to the standard Holmium laser when adjusted on the same power settings. This study will compare the efficacy and safety of Holmium MOSES and TFL in management of kidney stones requiring treatment.

Conditions

Interventions

TypeNameDescription
DEVICEThulium Fibre LaserParticipants will undergo treatment using the TFL
DEVICEMOSES Holmium LaserParticipants will undergo treatment using the MOSES Holmium laser.

Timeline

Start date
2022-08-16
Primary completion
2026-06-01
Completion
2026-09-01
First posted
2022-10-28
Last updated
2024-08-07

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05598645. Inclusion in this directory is not an endorsement.